Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 367 | 1.022 (1.005–1.039) | 0.009 | 1.037 (1.017–1.057) | < 0.001 |
Histologic grade | 361 | Â | Â | Â | Â |
G1 | 10 | Reference | Â | Â | Â |
G2 | 134 | 1.648 (0.400–6.787) | 0.489 |  |  |
G3 | 217 | 2.174 (0.535–8.832) | 0.278 |  |  |
Gender | 370 | Â | Â | Â | Â |
Female | 133 | Reference | Â | Â | Â |
Male | 237 | 1.267 (0.891–1.804) | 0.188 |  |  |
Stage I | 50 | Reference | Â | Reference | Â |
Stage II | 110 | 1.551 (0.782–3.078) | 0.209 | 1.529 (0.516–4.528) | 0.443 |
Stage III | 149 | 2.381 (1.256–4.515) | 0.008 | 1.487 (0.360–6.139) | 0.583 |
Stage IV | 38 | 3.991 (1.944–8.192) | < 0.001 | 3.317 (0.764–14.410) | 0.110 |
Pathologic T stage | 362 | Â | Â | Â | Â |
T1 | 18 | Reference | Â | Reference | Â |
T2 | 78 | 6.725 (0.913–49.524) | 0.061 | 3.606 (0.451–28.806) | 0.226 |
T3 | 167 | 9.548 (1.326–68.748) | 0.025 | 4.013 (0.449–35.894) | 0.214 |
T4 | 99 | 9.634 (1.323–70.151) | 0.025 | 3.851 (0.417–35.570) | 0.235 |
Pathologic N stage | 352 | Â | Â | Â | Â |
N0 | 107 | Reference | Â | Reference | Â |
N1 | 97 | 1.629 (1.001–2.649) | 0.049 | 1.220 (0.600–2.480) | 0.583 |
N2 | 74 | 1.655 (0.979–2.797) | 0.060 | 1.447 (0.607–3.449) | 0.404 |
N3 | 74 | 2.709 (1.669–4.396) | < 0.001 | 1.847 (0.779–4.376) | 0.163 |
Pathologic M stage | 352 | Â | Â | Â | Â |
M0 | 327 | Reference | Â | Reference | Â |
M1 | 25 | 2.254 (1.295–3.924) | 0.004 | 1.255 (0.537–2.936) | 0.600 |
GLA | 370 | 0.799 (0.615–1.039) | 0.094 | 0.786 (0.556–1.109) | 0.170 |
LAMC1 | 370 | 1.226 (1.047–1.435) | 0.011 | 1.296 (1.089–1.543) | 0.004 |
TRAF2 | 370 | 0.768 (0.590–0.999) | 0.049 | 0.771 (0.541–1.098) | 0.150 |